Select Page

News, Resources, Updates

A scientific hub to keep you informed about our latest research and company updates.

Eurostars grant for MINDMAP

53 million people were affected by Alzheimer’s Disease (AD) in 2013. This was a steep rise from 26.6 million in 2005, and the predictions for 2050 rise further to 106 million cases. Despite the growing demand for AD medicines not only to stabilize but also to treat...

read more

Be the first to know – get this news straight to your inbox

InnoSer provides a variety of validated in vitro and in vivo platforms for the efficient development of novel therapeutics. If you require additional information, feel free to reach out, and we will respond within a few days.

We provide a monthly update from our InnoSer labs containing scientific insights into our research services. To get news straight to your inbox please sign up here.